MedPath

Iron Supplementation in Hip/Knee Surgery

Not Applicable
Completed
Conditions
Anemia
Iron Poor Blood
Orthopedic Disorder
Knee Arthropathy
Hip Arthropathy
Interventions
Dietary Supplement: Sucrosomial iron plus ascorbic acid
Registration Number
NCT04078880
Lead Sponsor
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Brief Summary

Randomized controlled trial to evaluate the efficacy of oral iron supplementation in reducing the prevalence of preoperative anemia in a cohort of 82 patients undergoing elective prosthetic hip or knee surgery.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
82
Inclusion Criteria
  • Males and females
  • ASA 1, 2, or 3
  • No neuropsychiatric conditions
  • Acceptance of informed consent
  • Elective prosthetic hip or knee surgery
Exclusion Criteria
  • ASA 4
  • Present or past neuropsychiatric conditions
  • Hip or knee revision surgery
  • Use of iron as dietary supplement
  • Known erythrocytosis
  • Incompatible hypersensitivities
  • Iron metabolism disorders
  • Lymphoproliferative disorders

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Intervention (group A)Sucrosomial iron plus ascorbic acidPatients who are subjected to the intervention, being iron plus ascorbic acid, other than the standard of care.
Primary Outcome Measures
NameTimeMethod
Change of blood hemoglobin levelsBaseline and 30 days +/- 5 days

CHange of hemoglobin concentration (g/dl) from baseline and after 30 days +/- 5 days

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

IRCCS Istituto Ortopedico Galeazzi

🇮🇹

Milan, Italy

© Copyright 2025. All Rights Reserved by MedPath